1 in 8 women will be diagnosed with breast cancer in their lifetime, making it the most common cancer found in women. We know firsthand the impact technology can have to end breast cancer. In honor of Breast Cancer Awareness Month, we’re shedding light on innovative FemTech companies and the women involved that are transforming breast cancer research.
With AI technology able to predict if you’ll develop breast cancer within the next 5 years, Constance Lehman, MD, Ph.D., co-founded her startup company, Clairity. This AI technology allows computers to look at a mammogram and ingest large volumes of data to be analyzed at a pixel level, giving a more accurate reading. Reducing the amount of treatment needed if detected at an early stage, her technology gives patients peace of mind with less treatment and lower cost. Lehman is taking things further by allocating resources to underrepresented groups who are often left behind in the mammogram process. Clairity has recently released plans of expanding their AI technology for lung cancer and certain cardiovascular and neurological screenings.
With patented technology revolutionizing how we diagnose cancer, 4D Path was founded in 2016 by Satabhisa Mukhopadhyay, Ph.D. and her team. Mukhopadhyay and her team defied odds through the pandemic and raised enough funding to create their first device. Named the “first-of-its-kind fully automated ‘breakthrough device’”, the 4D Q-plasia OncoReader Breast provides digitized histopathology images from biopsies to improve the accuracy of breast cancer diagnoses, reducing the need for surgical intervention. While Mukhopadhyay and her team are making massive strides for breast cancer, they’re also expanding their focus to include ovarian, skin, and cervical cancer.
Cancer is one of the most complex diseases, giving experts countless hurdles to jump in trying to find a cure. That’s where Olea Medical comes in, streamlining the cancer treatment process. Anca Mitulescu, VP of Clinical Affairs at Olea Medical, explains that their first product, Olea Sphere, speeds up the processing time of a diagnosis and can help evaluate pathologies like breast cancer in a more effective way, successfully standardizing even the most complex MRI sequences. In recent years, Mitulescu and her team have been in the works of creating a solution for breast lesions assessments, a major breakthrough in women's imaging, helping doctors be more confident in making a diagnosis.
Coupled with artificial intelligence and automated ultrasound, Maryam Ziaei, Ph.D., and Shadi Saberi, Ph.D., founded iSonoHealth. With patient comfort in mind, they created the world's first portable AI-driven 3D breast ultrasound scanner, the ATUSA. Eliminating the need for an ultrasound operator, the ATUSA captures imaging of the breast in just one minute with their wearable accessory. This not only simplifies the process for practitioners but also gives patients a seamless and painless experience.
We still have a long road ahead to find a cure, but we applaud these extraordinary FemTech companies in making enormous strides in fighting breast cancer. With only 25% of women being in the tech industry, these amazing women and their dedicated teams are fighting for women across the globe while simultaneously being inspirational leaders.
In honor of Breast Cancer Awareness Month, we’re donating 5% of proceeds from all pink TickTalk 4 orders to breast cancer research. Get peace of mind that your child stays safely connected while supporting a great cause at the same time!